Sponsor Led Roundtable: Utilizing Innovative Strategies and Collaborations to Address Challenges in Neurodegenerative Trials [Clinical Studies Topic]
					 24 Jun 2024
				
				
                        
                        
                            
					        	
					        	
					        	Drug Delivery
					        
                        
                	
				
			
				- How have advancements in science and technology transformed the landscape of degenerative neurological disease trials?
 - What are the challenges and delays caused by factors like neurological biomarkers, novel therapies, FDA requirements, patient recruitment, and the inclusion of diverse age groups?
 - How can we address the complexities and obstacles in today's degenerative neurology trials to keep them on track?
 - What role do wearable devices play in these trials, and how can we improve their acceptance among patients?
 - How can partnering with small and mid-sized CROs mitigate risks and ensure the efficacy of innovative treatments in degenerative neurology trials?
 


